VISINE

This brand name is authorized in Germany, Ecuador, Estonia, Croatia, Israel, Lithuania, New Zealand, Poland, Romania, Turkey

Active ingredients

The drug VISINE contains one active pharmaceutical ingredient (API):

1 Tetryzoline UNII S9U025Y077 - TETRAHYDROZOLINE

Tetryzoline is an alpha adrenergic receptor agonist, which is used in form of nasal solution or spray for decongestion of nasal and nasopharyngeal mucosa. Read about Tetryzoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01GA02	Tetryzoline	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GA Sympathomimetics used as decongestants
Discover more medicines within S01GA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 04081171, 05965469, 15298442
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 362621012, 6862-MEE-1221
Country: EE	Ravimiamet	Identifier(s): 1016648, 1790085
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-564603810
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1185
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008061, 1066847, 1085843, 1092181
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 532, 8922
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100070747, 100418469, 100425179
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64914001, W64914002, W67737001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683873461424